NORIS, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.809
EU - Europa 2.904
AS - Asia 2.048
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
SA - Sud America 4
Totale 8.797
Nazione #
US - Stati Uniti d'America 3.779
CN - Cina 2.001
IE - Irlanda 960
UA - Ucraina 471
FI - Finlandia 406
SE - Svezia 291
DE - Germania 263
IT - Italia 252
GB - Regno Unito 122
FR - Francia 55
CA - Canada 30
IN - India 24
RU - Federazione Russa 22
AU - Australia 16
BE - Belgio 16
RO - Romania 16
EU - Europa 9
IR - Iran 9
NL - Olanda 8
GR - Grecia 7
MU - Mauritius 5
SG - Singapore 5
CZ - Repubblica Ceca 4
JP - Giappone 3
AR - Argentina 2
CH - Svizzera 2
DK - Danimarca 2
PT - Portogallo 2
TR - Turchia 2
AL - Albania 1
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
ET - Etiopia 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.797
Città #
Dublin 960
Chandler 873
Jacksonville 661
Nanjing 613
Ashburn 286
Nanchang 224
Princeton 194
Shenyang 183
Wilmington 181
Lawrence 180
Medford 177
Hebei 165
Changsha 164
Beijing 159
Jiaxing 128
Helsinki 96
Tianjin 90
Ann Arbor 89
Hangzhou 88
Boardman 86
Milan 67
Shanghai 53
Woodbridge 47
New York 41
Pavia 40
Houston 39
Verona 32
Fairfield 28
Los Angeles 25
Norwalk 25
Toronto 23
Pune 19
Seattle 18
Guangzhou 17
Brussels 16
Des Moines 14
Jinan 14
Falls Church 12
Timisoara 12
Zhengzhou 12
Auburn Hills 11
Rome 9
Sydney 9
Ningbo 8
Palermo 8
Kunming 7
Taizhou 7
Tappahannock 7
Andover 6
San Francisco 6
Fuzhou 5
Moscow 5
Orange 5
Washington 5
Dearborn 4
Leawood 4
Melbourne 4
Monmouth Junction 4
Redwood City 4
Saint Petersburg 4
Bari 3
Bologna 3
Borås 3
Brescia 3
Brno 3
Changchun 3
Chongqing 3
Falkenstein 3
Laives 3
Lanzhou 3
Padova 3
Sacramento 3
Singapore 3
Tokyo 3
Aprilia 2
Ardabil 2
Caserta 2
Chicago 2
Frankfurt am Main 2
Genoa 2
Haarlem 2
Mariglianella 2
Montreal 2
Munich 2
Ottawa 2
Paris 2
Pieve Emanuele 2
Pisa 2
Porto 2
Redmond 2
Rho 2
Rockville 2
Shijiazhuang 2
St Petersburg 2
Tehran 2
Teramo 2
Travedona Monate 2
Turin 2
Vezia 2
Zanjan 2
Totale 6.367
Nome #
Antigeni minori di istocompatibilità 116
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 80
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 80
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 77
Spectrum of the mutations in Bernard-Soulier syndrome. 77
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 77
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 75
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 75
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 72
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 71
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 70
A HOMOZYGOUS POINT MUTATION IN A LEUCINE-RICH MOTIF OF PLATELET GLYCOPROTEIN-IX ASSOCIATED WITH BERNARD-SOULIER SYNDROME (BSS) 70
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NATP) CAUSED BY A NEW LOW-FREQUENCY PLATELET-SPECIFIC ALLOANTIGEN, MAXA, LOCATED ON GPIIB 69
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 68
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 68
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 68
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 68
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 67
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 67
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 67
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 66
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 65
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 65
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 65
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders 65
Inherited thrombocytopenias in the era of personalized medicine 64
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 64
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 64
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 64
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 62
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 62
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 62
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 62
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 62
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 62
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 61
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 61
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 61
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 61
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 61
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 60
Desmopressin and platelets: In vitro and in vivo studies 60
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 60
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 60
Platelet-independent defect in hemostasis associated with sirolimus use 60
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 59
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 59
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 59
May-Hegglin anomaly: Clinical and laboratory investigation of 14 cases 59
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 59
Platelet count and aging 58
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 58
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function 58
Haemophagocytic syndrome responding to high-dose gamma-globulin as presenting feature of sarcoidosis. 58
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 58
Incompatibility at CD31, HPA3 or HPA5 loci are HLA-A2-restricted risk factors for acute GVHD. 58
Inherited thrombocytopenias. The evolving spectrum. 58
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 58
In vitro and in vivo effects of desmopressin on platelet function 58
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. 57
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 57
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 57
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 57
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 57
A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. 56
Ristocetin-induced platelet agglutination stimulates GPIIb-IIIa-dependent calcium influx. 56
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 56
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 56
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 56
Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation 55
Von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets. 55
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopenia. 55
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 55
Effetto del Diltiazem sulla funzionalità piastrinica ex vivo 55
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 55
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 55
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 54
ANKRD26-related thrombocytopenia and myeloid malignancies 54
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 54
Megakaryocytes derived from patients with the classical form of Bernard-Soulier syndrome show no ability to extend proplatelets in vitro. 53
Is thiazole orange fluorescence of human platelets directly related to their age? 53
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 53
Cys209 Ser mutation in the platelet membrane glycoprotein Ib alpha gene is associated with Bernard-Soulier syndrome 53
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 53
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 52
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 52
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 52
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 51
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study 51
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 51
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 50
In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts? 49
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 49
Safety and efficacy of low dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment. The FONDAIR study. 49
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 49
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 49
Mean platelet volume for distinguishing between inherited thrombocytopenias and immune thrombocytopenia - response to Beyan 48
Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy 48
Genetic heterogeneity of autosomal dominant nonsyndromic macrothrombocytopenias 48
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 48
Totale 6.031
Categoria #
all - tutte 33.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.258 692 968 5 84 2 101 27 103 12 182 76 6
2020/20211.012 101 90 34 85 9 123 8 156 80 152 138 36
2021/2022913 24 1 32 17 36 48 14 53 53 35 108 492
2022/20232.615 273 158 15 232 265 271 5 138 1.122 21 67 48
2023/2024890 113 125 33 82 107 240 19 58 11 39 37 26
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 9.189